Dutasteride

BRAND NAMES

1. Avodart – the primary and most widely recognized brand 

2. Duodart – a combination formulation with tamsulosin for benign prostatic hyperplasia.

MECHANISM OF ACTION

Dutasteride works by inhibiting the enzyme 5-alpha-reductase, which is responsible for converting testosterone into dihydrotestosterone (DHT), a more potent androgen. DHT is a key hormone involved in the enlargement of the prostate in benign prostatic hyperplasia (BPH) and contributes to hair loss in androgenetic alopecia.

PHARMACOKINETICS

Absorption

Dutasteride is well absorbed orally, with peak plasma concentrations (Cmax) typically reached 2–3 hours after a single dose. Its oral bioavailability is approximately 60%, and absorption is not significantly affected by food, so it can be taken with or without meals.

Distribution

Dutasteride has a large apparent volume of distribution, approximately 300–500 L, indicating extensive distribution into body tissues.

Metabolism

Dutasteride is extensively metabolized in the liver, primarily by the cytochrome P450 enzyme CYP3A4. It undergoes oxidative metabolism to form several inactive metabolites, which have minimal or no pharmacological activity.

Elimination

Dutasteride is primarily eliminated through fecal excretion of its metabolites, with only a small fraction (<5%) excreted unchanged in the urine.

PHARMACODYNAMICS

Dutasteride exerts its pharmacological effects by inhibiting both type I and type II 5-alpha-reductase enzymes, which are responsible for converting testosterone into dihydrotestosterone (DHT), a potent androgen. By reducing DHT levels by up to 90%, dutasteride decreases prostate volume, improves urinary flow, and alleviates lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). The suppression of DHT is gradual, with clinical effects typically observed after 3–6 months of treatment.

ADMINISTRATION

Dutasteride is administered orally in the form of soft gelatin capsules, usually at a dose of 0.5 mg once daily. It can be taken with or without food, and capsules should be swallowed whole without chewing or crushing to maintain proper absorption.

DOSAGE AND STRENGTH

Dutasteride is commonly available in 0.5 mg soft gelatin capsules. The standard recommended dose for the treatment of benign prostatic hyperplasia (BPH) is 0.5 mg orally once daily. The dosage is generally fixed and does not require adjustment for most patients, although caution may be needed in those with severe hepatic impairment.

DRUG INTERACTIONS

Dutasteride can interact with other drugs primarily due to its metabolism by CYP3A4 and its effects on androgen levels. Concomitant use with CYP3A4 inhibitors such as ketoconazole or ritonavir may increase dutasteride plasma concentrations, potentially raising the risk of adverse effects, while CYP3A4 inducers like rifampin or carbamazepine may reduce its effectiveness.

FOOD INTERACTIONS

Dutasteride has no significant food interactions and can be taken with or without meals. Food does not affect its absorption or bioavailability, so patients can take it at a convenient time that best supports adherence.

CONTRAINDICATIONS

Dutasteride is contraindicated in patients with a known hypersensitivity to the drug or any of its components. It must not be used by women who are or may become pregnant, as it is teratogenic and can cause abnormalities in a male fetus; pregnant women should avoid handling crushed or broken capsules.

SIDE EFFECTS

• Impotence (erectile dysfunction) 

• Decreased libido 

• Ejaculation disorders (e.g., decreased volume, retrograde ejaculation) 

• Breast tenderness or enlargement (gynecomastia) 

• Dizziness

OVER DOSAGE

Overdose with dutasteride is rare due to its standard once-daily dosing and long half-life, but taking excessive amounts may increase the likelihood of adverse effects, particularly those related to sexual function and dizziness.

TOXICITY

Dutasteride exhibits low acute toxicity, but excessive exposure can amplify its known side effects, particularly those related to sexual function, such as decreased libido, erectile dysfunction, and ejaculation disorders, as well as dizziness or hypotension.